Physician profile
Matthew D Collard
NPI 1346276383
$7,471.56
in general payments reported to CMS, 2019-2025
16 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,062 · 2020: $237 · 2021: $611 · 2022: $2,102 · 2024: $352 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $5,809.27 | 2019-2022 | |
| Depuy Synthes Sales INC. | $1,018.57 | 2019-2025 | Monovisc |
| Medical Device Business Services, INC. | $122.07 | 2022 | |
| Globus Medical, INC. | $98.19 | 2019 | |
| Skeletal Dynamics INC | $90.64 | 2019 | |
| Smith+Nephew, INC. | $79.98 | 2019 | |
| Bioventus LLC | $43.08 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $42.65 | 2024 | Vistaseal |
| Vertex Pharmaceuticals Incorporated | $40.67 | 2025 | |
| Medtronic USA, INC. | $32.54 | 2019 | |
| Convatec INC. | $22.57 | 2019 | |
| Arthrex, INC. | $16.00 | 2021 | |
| Endo Pharmaceuticals INC. | $15.54 | 2020 | |
| Zimmer Biomet Holdings, INC. | $14.53 | 2022 | |
| Innovation Technologies INC | $13.73 | 2025 | Irrisept |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Collard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.